Injective Protocol
Name
Injective Protocol
Summary
Injective Protocol is a universal Decentralized Finance (DeFi) protocol for cross-chain derivatives trading across a plethora of financial products such as perpetual swaps, futures, and spot trading.
Users can create any financial market on Injective’s fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol.
Rating
Symbol
INJ
Overview
The Injective Chain is custom built to support Ethereum-compatible DeFi applications that reach instant finality, sub 2 second block times, and lightning fast transaction speeds (10,000+ TPS).
Users on Injective can seamlessly trade across distinct blockchain networks such as Ethereum, Cosmos, and Binance Smart Chain. Injective is also able to facilitate trades across Cosmos-based projects such as Terra.
The project has a buyback and buy burn mechanism funded by 60% of the exchange fees and is triggered every two weeks. As the Injective ecosystem develops greater network usage, new ecosystem projects would contribute towards the token burn and reduce the supply of INJ over time.
Historical Price Movement (in INR)
Technology
The Injective Chain is implemented as a Cosmos SDK module, built with Ethermint (EVM on Tendermint). It utilizes a Tendermint-based Proof-of-Stake to facilitate cross chain derivatives trading across Cosmos, Ethereum, and many other layer-1 protocols.
Injective Protocol is collision resistant and utilizes Verifiable Delay Function (VDF) to prevent front-running.
The Injective Protocol blockchain operates on a Tendermint-based proof-of-stake (PoS) consensus mechanism. Prominent validators help to secure the network while making it more decentralized as well.
Injective’s consensus mechanism achieves instant transaction finality while leading to a 99% lower carbon footprint.
Use of Native tokens in the ecosystem:
INJ is the native token of Injective Protocol. INJ is a scarce asset that is used for governance, exchange value capture, liquidity mining, and staking.
Ecosystem Development
36.33%
Token sale
31.7%
Team and Advisors
22%
Community Growth
10%
Volume ( as of 25th april 2022)
$10,789,426
Total Supply
100,000,000 INJ
Circulating Supply
48,655,554 INJ
Crowd Sales
20/10/2020- ICO- $3.6M
Funding
20/04/2021- Series A funding round- $10M
29/07/2020- Seed/Venture round - $3.5M
Country
United States
Name of Organisation
Injective Labs Inc.
Year Incorporated
2021
Registered Address
8171 BRITTANY DR DUBLIN CA 94568
Dispute Resolution and Governing Law
United States
Country Risk Assessment
A1
Founding Team
| Name | Designation | Education | Experience |
| Eric Chen | Co-Founder | - | 4 yrs |
| Albert Chon | CTO | Stanford University: MS, Computer Science - Specialization in Systems | 8 yrs |
